Plasmin-α2-antiplasmin complex

Source: Wikipedia, the free encyclopedia.

Plasmin-α2-antiplasmin complex (PAP) is a 1:1 irreversibly formed inactive complex of the

fibrinolytic system and a marker of net activation of fibrinolysis.[5][6]

PAP levels are increased with

menopausal hormone therapy.[6] PAP levels have been reported to be elevated in men with prostate cancer.[8]

References